about
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentinCitrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodiesThe antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodiesAre synovial biopsies of diagnostic value?Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic valueIdentification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritisCitrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severityTherapeutic implications of autoantibodies in rheumatoid arthritisClinical biomarkers and pathogenic-related cytokines in rheumatoid arthritisCitrullination-dependent differential presentation of a self-peptide by HLA-B27 subtypesImmune recognition of citrullinated epitopes.Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis.Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium.Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes.Antiperinuclear factor and keratin antibodies in rheumatoid arthritis.Significance of laminar antikeratin antibodies to rat oesophagus in rheumatoid arthritis.Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays.Antibodies to citrullinated protein antigens (ACPAs): clinical and pathophysiologic significanceCorrelation of anti-cyclic citrullinated antibody with hand joint erosion score in rheumatoid arthritis patients.Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis.Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritis.Progress in the use of biochemical and biological markers for evaluation of rheumatoid arthritis.Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis.Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis.Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts.Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays.Autoantibodies in rheumatoid arthritis and their clinical significance.Protein microarrays: a new tool for the study of autoantibodies in immunodeficiencyAnti-perinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides.Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis.Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis.Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage.Clinical utility of the anti-CCP assay in patients with rheumatic diseases.Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvementAre there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis?Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritisAutoantibodies to citrullinated (poly)peptides: a key diagnostic and prognostic marker for rheumatoid arthritis.Meta-Analysis: Diagnostic Accuracy of Anti-Carbamylated Protein Antibody for Rheumatoid Arthritis.Normal human epidermal keratinocytes express in vitro specific molecular forms of (pro)filaggrin recognized by rheumatoid arthritis-associated antifilaggrin autoantibodies.Antibodies to citrullinated peptides: a significant step forward in the early diagnosis of rheumatoid arthritis.
P2860
Q21195679-237B5071-0032-4763-AD50-45B712AE8D75Q24564876-BDD69464-F997-42DF-ADC4-EED65845F96FQ24628871-EEC67909-4B4A-4018-A492-201782BC185DQ24795018-530E4701-62BD-4BA7-AB83-4479D63670DEQ24806041-92C539F3-DBB5-4E25-8FB1-B6E4A344161BQ24813085-0BDE65A6-F3F5-4FBA-A1A5-7589FD59F417Q24816615-017AF8AB-8DC0-4E52-9142-E08F221400FDQ26744033-9716AA73-BDE2-4671-9F0B-163FC8C7DAC4Q27022559-93726561-2A2B-4400-802E-AA462A163533Q27651301-53884713-B106-4000-BFB3-B74B29E6081DQ30391892-5F1283CF-17FF-4874-99B2-61DD8B13073FQ32045081-E1441EA5-03CE-438C-975D-3D970057B211Q33399862-D399888C-F0BC-4E8F-89FD-75E0E4636189Q33417857-EC78B737-87F2-426A-B503-761D598866A3Q33553139-81D87026-7FB0-41D9-BB78-D2C778D7F93DQ33553150-D6224D4C-0FE4-44AE-A09B-EBB290077FCDQ33840439-E828161E-A2D4-451E-B175-BEE9DED548DFQ33893385-9D6643C3-4E32-41EB-850D-DAEDA5797001Q33893960-93316B24-F9D3-47B7-9A9D-341258BCE6C6Q33986960-19B300B3-9318-4466-8267-55F8A9D0732BQ34063418-9AA697DC-80D7-4B5C-8E48-DE97527EE4CFQ34118568-485BF881-BB82-443D-8277-CC9425CB1170Q34250833-39856D75-D1DA-4273-91B5-C86B05CC84D3Q34498921-C5F2213A-4A4D-4931-97D2-321E6FF20520Q34635933-7F8323CE-A24E-462F-90FB-938F9A0BFC8DQ34652565-CC4BEFE5-D836-4286-B598-764B052532B9Q34731269-7BEBF9A4-F2CD-444F-8A99-760D1566AB4FQ35296572-3A224371-0685-413A-8E86-6F30157DCDC9Q35548224-EFCED43B-80F9-42E2-99D2-9A2ED29CCFF0Q35550461-17FB4367-F288-4398-B2A3-752794FA0745Q35550790-1FD4F532-200B-484A-9F39-F3BE2DEC0C14Q35552357-05F790CF-9348-486C-BBCD-BB027131D328Q35553110-E9410688-3863-4DF0-A3E7-2A14CDB55BB5Q35553375-B508834B-BE36-4D9A-8394-DC7457E54D51Q35554779-B2939C9A-DD3A-40D7-8940-B59C0ABA651AQ35555882-D02B69BF-F07D-45B4-9A97-BFBC8E28E460Q35934700-FB2180F9-42EB-4568-BA1C-B5DDCDEC2FF2Q36082681-E4DADD18-C941-4B15-951F-B5989708B117Q36437718-9537D682-170D-4856-A890-8C4759BAA195Q36740473-B59C1C21-E0E8-4AA0-A492-911156B4816A
P2860
description
1979 nî lūn-bûn
@nan
1979 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
name
Anti-keratin antibodies in rheumatoid arthritis
@ast
Anti-keratin antibodies in rheumatoid arthritis
@en
Anti-keratin antibodies in rheumatoid arthritis
@nl
type
label
Anti-keratin antibodies in rheumatoid arthritis
@ast
Anti-keratin antibodies in rheumatoid arthritis
@en
Anti-keratin antibodies in rheumatoid arthritis
@nl
prefLabel
Anti-keratin antibodies in rheumatoid arthritis
@ast
Anti-keratin antibodies in rheumatoid arthritis
@en
Anti-keratin antibodies in rheumatoid arthritis
@nl
P2093
P2860
P3181
P356
P1433
P1476
Anti-keratin antibodies in rheumatoid arthritis
@en
P2093
R D Leslie
R K Mallya
T J Hamblin
P2860
P3181
P356
10.1136/BMJ.2.6182.97
P407
P577
1979-07-14T00:00:00Z